See also this year's filing and all EDGAR filings for this company.
PDF Report 0001626971_2021_Corvus_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001626971, Corvus Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 45,336,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 906,000 |
| 3 | remainder_Assets | 39,287,000 |
| 4 | LiabilitiesCurrent | 12,149,000 |
| 5 | LiabilitiesNoncurrent | 1,232,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,437,813 |
| 9 | ResearchAndDevelopmentExpense | 29,072,764 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 5,693,515 |
| 13 | remainder_ComprehensiveNetIncome | 62,836 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 85,529,000 |
| 1 | Liabilities | 13,381,000 |
| 2 | Expenses | 41,510,577 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 72,148,000 |
| 5 | NetIncome | -35,817,062 |
| 6 | ComprehensiveNetIncome | -35,785,644 |
| 7 | BaseVar | 73,088,464 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.46 |
| 9 | EconomicCapitalRatio | 3.33 |
Edgar->Model Mapping
Feature Distribution
Change over Time
